Related Experiment Video
Updated: Sep 1, 2025

11:11
Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
8.3K
Pathogenic Roles of RNA-Binding Proteins in Sarcomas
Yu Hai1,2, Asuka Kawachi1, Xiaodong He2
1Cancer RNA Research Unit, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Cancers
|August 12, 2022
Summary
RNA-binding proteins (RBPs) are crucial in regulating RNA metabolism and are implicated in sarcoma development. Understanding RBP-RNA interactions can reveal new therapeutic targets for this challenging cancer.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- RNA-binding proteins (RBPs) regulate critical RNA metabolic processes.
- Dysregulated RBPs are increasingly linked to the pathogenesis of various malignant tumors, including sarcomas.
- Sarcoma patients, particularly those with advanced disease, have a poor prognosis and limited treatment options.
Purpose of the Study:
- To investigate the role of RNA-binding proteins (RBPs) in sarcoma development.
- To elucidate the network of interactions between RBPs and disease-related RNA targets in sarcomagenesis.
- To identify novel therapeutic targets for sarcoma based on a deeper understanding of its pathogenesis.
Main Methods:
- This study focuses on defining the interaction network between RBPs and disease-related RNA targets.
- The research involves analyzing the functional and physical binding of RBPs to RNA.
- Methods will likely include molecular biology techniques to study RNA metabolism regulation.
Main Results:
- Accumulating evidence suggests RBPs play an essential role in sarcoma pathogenesis.
- Understanding RBP-RNA interactions is key to unraveling sarcomagenesis.
- Identifying these interactions may lead to novel therapeutic strategies.
Conclusions:
- Defining the RBP-RNA interaction network is crucial for understanding sarcoma.
- This research aims to identify novel therapeutic targets for sarcomas.
- Further investigation into RBPs offers hope for improved sarcoma treatment.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
Types of RNA
64.5K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.5K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Translational Regulation
81
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
81
RNA Splicing
56.7K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.7K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K

